Unknown

Dataset Information

0

Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.

ABSTRACT: Introduction section, para 3, lines 2-4 which previously read.

SUBMITTER: Qi Y 

PROVIDER: S-EPMC6828067 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.

Qi Yulan Y   McKeever Kathleen K   Taylor Julie J   Haller Christine C   Song Wenjie W   Jones Simon A SA   Shi Jack J  

Clinical pharmacokinetics 20190501 5

Introduction section, para 3, lines 2-4 which previously read. ...[more]

Similar Datasets

Unknown Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.
| S-EPMC6451706 | biostudies-literature
Unknown Open-label phase 1/2 study of vestronidase alfa for mucopolysaccharidosis VII.
| S-EPMC8178115 | biostudies-literature
Unknown Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population.
| S-EPMC6718107 | biostudies-literature
Unknown Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome.
| S-EPMC4243006 | biostudies-literature
Unknown Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.
| S-EPMC11077874 | biostudies-literature
Unknown Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model.
| S-EPMC3444660 | biostudies-literature
Unknown Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.
| S-EPMC9426762 | biostudies-literature
Unknown Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data.
| S-EPMC8535651 | biostudies-literature
Unknown Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA.
| S-EPMC9248211 | biostudies-literature
Unknown Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.
| S-EPMC1224072 | biostudies-literature